A week in Japan tech
- Merck's $1.5 billion takeover of Banyu Pharmaceutical takes another turn, eight days before the U.S. drug giant's offer expires. A Banyu shareholder who contends that he has acquired enough support from other shareholders to block the deal says he sent a letter to the Japanese firm, urging it to oppose Merck's offer. It also requests that Banyu immediately hire an independent financial adviser.
- Oji Paper...